Published in Trends Pharmacol Sci on April 01, 2003
Neurocircuitry of addiction. Neuropsychopharmacology (2010) 14.22
Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol (2007) 3.06
Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products. Neuropsychopharmacology (2012) 2.28
Dopamine responsiveness is regulated by targeted sorting of D2 receptors. Proc Natl Acad Sci U S A (2005) 1.55
Molecular basis for catecholaminergic neuron diversity. Proc Natl Acad Sci U S A (2004) 1.47
Animal models of attention-deficit hyperactivity disorder. Behav Brain Funct (2005) 1.47
Anabolic-androgenic steroid dependence? Insights from animals and humans. Front Neuroendocrinol (2008) 1.41
Progression of cellular adaptations in medial prefrontal and orbitofrontal cortex in response to repeated amphetamine. J Neurosci (2006) 1.38
Functional gene expression differences between inbred alcohol-preferring and -non-preferring rats in five brain regions. Alcohol (2007) 1.28
Divergent plasticity of prefrontal cortex networks. Neuropsychopharmacology (2007) 1.12
L-type Ca2+ channels mediate adaptation of extracellular signal-regulated kinase 1/2 phosphorylation in the ventral tegmental area after chronic amphetamine treatment. J Neurosci (2004) 1.12
Gene expression profiles of brain dopamine neurons and relevance to neuropsychiatric disease. J Physiol (2006) 1.00
Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence. Nebr Symp Motiv (2009) 1.00
History of childhood adversity is positively associated with ventral striatal dopamine responses to amphetamine. Psychopharmacology (Berl) (2014) 0.99
Region-specific effects of N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide on nicotine-induced increase in extracellular dopamine in vivo. Br J Pharmacol (2007) 0.97
Candidate genes for alcohol preference identified by expression profiling in alcohol-preferring and -nonpreferring reciprocal congenic rats. Genome Biol (2010) 0.96
Identification of candidate genes for alcohol preference by expression profiling of congenic rat strains. Alcohol Clin Exp Res (2007) 0.95
The Plasticity of Extinction: Contribution of the Prefrontal Cortex in Treating Addiction through Inhibitory Learning. Front Psychiatry (2013) 0.94
Individual differences in dopamine cell neuroadaptations following cocaine self-administration. Biol Psychiatry (2009) 0.93
Distinct roles of presynaptic dopamine receptors in the differential modulation of the intrinsic synapses of medium-spiny neurons in the nucleus accumbens. BMC Neurosci (2007) 0.93
Regulation of striatal dopamine release by presynaptic auto- and heteroreceptors. Basal Ganglia (2012) 0.92
Psychostimulants, L-type calcium channels, kinases, and phosphatases. Neuroscientist (2005) 0.91
Hypocretin mechanisms in nicotine addiction: evidence and speculation. Psychopharmacology (Berl) (2009) 0.87
Altered neurocircuitry in the dopamine transporter knockout mouse brain. PLoS One (2010) 0.86
'Roid rage in rats? Testosterone effects on aggressive motivation, impulsivity and tyrosine hydroxylase. Physiol Behav (2012) 0.86
The effects of mGluR2/3 activation on acute and repeated amphetamine-induced locomotor activity in differentially reared male rats. Exp Clin Psychopharmacol (2014) 0.85
Cocaine inhibition of nicotinic acetylcholine receptors influences dopamine release. Front Synaptic Neurosci (2014) 0.84
High doses of simvastatin upregulate dopamine D1 and D2 receptor expression in the rat prefrontal cortex: possible involvement of endothelial nitric oxide synthase. Br J Pharmacol (2005) 0.82
TLR4 signaling in VTA dopaminergic neurons regulates impulsivity through tyrosine hydroxylase modulation. Transl Psychiatry (2016) 0.79
Striatal dopamine neurotransmission: regulation of release and uptake. Basal Ganglia (2016) 0.79
Altered reward circuitry in the norepinephrine transporter knockout mouse. PLoS One (2013) 0.78
DISC1 signaling in cocaine addiction: Towards molecular mechanisms of co-morbidity. Neurosci Res (2015) 0.78
Environmental condition alters amphetamine self-administration: role of the MGluR₅ receptor and schedule of reinforcement. Psychopharmacology (Berl) (2015) 0.78
Effects of an epilepsy-causing mutation in the SCN1A sodium channel gene on cocaine-induced seizure susceptibility in mice. Psychopharmacology (Berl) (2013) 0.77
Development of peptidomimetic ligands of Pro-Leu-Gly-NH(2) as allosteric modulators of the dopamine D(2) receptor. Beilstein J Org Chem (2013) 0.77
Influence of verbal recall of a recent stress experience on anxiety and desire for cocaine in non-treatment seeking, cocaine-addicted volunteers. Am J Addict (2009) 0.77
Activation of adenosine A2A receptors suppresses the emission of pro-social and drug-stimulated 50-kHz ultrasonic vocalizations in rats: possible relevance to reward and motivation. Psychopharmacology (Berl) (2015) 0.77
Role of calcineurin in the VTA in rats behaviorally sensitized to methamphetamine. Psychopharmacology (Berl) (2011) 0.76
Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6. Transl Psychiatry (2015) 0.76
Social Isolation Blunted the Response of Mesocortical Dopaminergic Neurons to Chronic Ethanol Voluntary Intake. Front Cell Neurosci (2016) 0.75
Psychostimulants, Protein phosphorylation and Gene expression: a growing role of L-type calcium channels. Cellscience (2005) 0.75
Dopamine transporter mutant animals: a translational perspective. J Neurogenet (2016) 0.75
Effects of Ibudilast on the Subjective, Reinforcing and Analgesic Effects of Oxycodone in Recently Detoxified Adults with Opioid Dependence. Neuropsychopharmacology (2017) 0.75
Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood (2007) 6.03
Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron (2005) 3.30
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat Neurosci (2003) 3.25
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nat Neurosci (2008) 2.87
An isochore map of human chromosomes. Genome Res (2006) 2.36
Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci (2007) 2.19
Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. FEBS J (2009) 1.95
Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1. Proc Natl Acad Sci U S A (2004) 1.79
Cytosine methylation and CpG, TpG (CpA) and TpA frequencies. Gene (2004) 1.78
Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons. J Neurosci (2003) 1.66
Genomic GC level, optimal growth temperature, and genome size in prokaryotes. Biochem Biophys Res Commun (2006) 1.61
Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease. Eur J Neurosci (2009) 1.59
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J Neurosci (2009) 1.59
Interleukin-1β causes anxiety by interacting with the endocannabinoid system. J Neurosci (2012) 1.55
Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS. J Leukoc Biol (2003) 1.55
TNF-α-mediated anxiety in a mouse model of multiple sclerosis. Exp Neurol (2012) 1.55
Systemic delivery of recombinant brain derived neurotrophic factor (BDNF) in the R6/2 mouse model of Huntington's disease. PLoS One (2013) 1.50
Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome. Biol Psychiatry (2007) 1.48
Correlations between genomic GC levels and optimal growth temperatures in prokaryotes. FEBS Lett (2004) 1.48
SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain (2010) 1.45
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter. Eur J Neurosci (2011) 1.45
Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors. J Neurosci (2003) 1.41
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. J Neurosci (2002) 1.40
Unilateral spatial neglect and alien limb phenomenon may be early features of Creutzfeldt-Jakob disease. Parkinsonism Relat Disord (2012) 1.39
The evolution of isochore patterns in vertebrate genomes. BMC Genomics (2009) 1.38
Dopamine excites fast-spiking interneurons in the striatum. J Neurophysiol (2002) 1.36
Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors. PLoS One (2010) 1.36
Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine. Brain (2009) 1.35
A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. J Neurosci (2006) 1.34
Mutations in the ER-shaping protein reticulon 2 cause the axon-degenerative disorder hereditary spastic paraplegia type 12. J Clin Invest (2012) 1.32
Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity. J Neurosci (2003) 1.31
Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K/Akt pathway. J Neurosci (2009) 1.27
FcgammaRIII discriminates between 2 subsets of Vgamma9Vdelta2 effector cells with different responses and activation pathways. Blood (2004) 1.27
Localization of the gene-richest and the gene-poorest isochores in the interphase nuclei of mammals and birds. Gene (2002) 1.27
Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia. Ann Neurol (2003) 1.26
Striatal synaptic plasticity: implications for motor learning and Parkinson's disease. Mov Disord (2005) 1.26
The endocannabinoid system in targeting inflammatory neurodegenerative diseases. Trends Pharmacol Sci (2007) 1.23
Identification and enrichment of spermatogonial stem cells displaying side-population phenotype in immature mouse testis. FASEB J (2003) 1.22
Replication timing, chromosomal bands, and isochores. Proc Natl Acad Sci U S A (2008) 1.22
Involvement of transient receptor potential-like channels in responses to mGluR-I activation in midbrain dopamine neurons. Eur J Neurosci (2003) 1.19
Proposed chronic cerebrospinal venous insufficiency criteria do not predict multiple sclerosis risk or severity. Ann Neurol (2011) 1.19
Representing GC variation along eukaryotic chromosomes. Gene (2004) 1.18
Effects of anodal transcranial direct current stimulation on chronic neuropathic pain in patients with multiple sclerosis. J Pain (2009) 1.18
The new genes of rice: a closer look. Trends Plant Sci (2004) 1.17
P2X7 receptor modulation on microglial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat. J Cereb Blood Flow Metab (2006) 1.16
Voltage-dependent membrane potential oscillations of rat striatal fast-spiking interneurons. J Physiol (2003) 1.15
Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases. Prog Neurobiol (2004) 1.15
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA. Neuropsychopharmacology (2010) 1.14
N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors. Neuropsychopharmacology (2006) 1.14
The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy? Trends Pharmacol Sci (2005) 1.13
A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission. Neuropsychopharmacology (2004) 1.13
Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors. J Neurosci (2004) 1.13
Dopamine D2 receptor-mediated inhibition of dopaminergic neurons in mice lacking D2L receptors. Neuropsychopharmacology (2002) 1.13
Impaired striatal D2 receptor function leads to enhanced GABA transmission in a mouse model of DYT1 dystonia. Neurobiol Dis (2009) 1.12
Differential post-translational modifications of transthyretin in Alzheimer's disease: a study of the cerebral spinal fluid. Proteomics (2006) 1.11
Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6/2 mouse model of Huntington's disease. PLoS One (2010) 1.11
Activation of TRPV1 in the VTA excites dopaminergic neurons and increases chemical- and noxious-induced dopamine release in the nucleus accumbens. Neuropsychopharmacology (2005) 1.10
Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine. J Neurosci (2010) 1.10
Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors. Neuropsychopharmacology (2002) 1.10
Synaptic plasticity in the ischaemic brain. Lancet Neurol (2003) 1.09
Beneficial effects of rolipram in the R6/2 mouse model of Huntington's disease. Neurobiol Dis (2008) 1.09
Endogenous serotonin excites striatal cholinergic interneurons via the activation of 5-HT 2C, 5-HT6, and 5-HT7 serotonin receptors: implications for extrapyramidal side effects of serotonin reuptake inhibitors. Neuropsychopharmacology (2007) 1.09
TRPV1 channels facilitate glutamate transmission in the striatum. Mol Cell Neurosci (2008) 1.08
Effects of epilepsy treatment on sleep architecture and daytime sleepiness: an evidence-based review of objective sleep metrics. Epilepsia (2014) 1.07
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism. J Neurosci (2004) 1.06
Dopamine, acetylcholine and nitric oxide systems interact to induce corticostriatal synaptic plasticity. Rev Neurosci (2003) 1.06
Late-onset CMT2 associated with a novel missense mutation in the cytoplasmic domain of the MPZ gene. Clin Neurol Neurosurg (2010) 1.06
Isochore pattern and gene distribution in the chicken genome. Gene (2007) 1.06
Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis. Ann Neurol (2012) 1.05
Characterization of human Enah gene. Biochim Biophys Acta (2006) 1.05
Mitochondrial damage modulates alternative splicing in neuronal cells: implications for neurodegeneration. J Neurochem (2006) 1.04
Isochore patterns and gene distributions in fish genomes. Genomics (2007) 1.04
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. Mult Scler (2010) 1.04
The short-sequence designs of isochores from the human genome. Proc Natl Acad Sci U S A (2008) 1.03
Temperature sensitivity of dopaminergic neurons of the substantia nigra pars compacta: involvement of transient receptor potential channels. J Neurophysiol (2005) 1.03
Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum. J Neurosci (2008) 1.02
Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis. Brain Behav Immun (2010) 1.02
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum. Eur J Neurosci (2002) 1.02
Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis. Neurol Sci (2009) 1.02
Mapping DNase-I hypersensitive sites on human isochores. Gene (2008) 1.01
A compact view of isochores in the draft human genome sequence. FEBS Lett (2002) 1.01
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. Brain (2007) 1.01
The correlation between genomic G+C and optimal growth temperature of prokaryotes is robust: a reply to Marashi and Ghalanbor. Biochem Biophys Res Commun (2005) 1.01
Pathological synaptic plasticity in the striatum: implications for Parkinson's disease. Neurotoxicology (2005) 1.00
DNA methylation and body temperature in fishes. Gene (2006) 1.00
Cholinergic dysfunction alters synaptic integration between thalamostriatal and corticostriatal inputs in DYT1 dystonia. J Neurosci (2012) 0.99
Gene-rich and gene-poor chromosomal regions have different locations in the interphase nuclei of cold-blooded vertebrates. Chromosoma (2006) 0.99
Human chromosomal bands: nested structure, high-definition map and molecular basis. Chromosoma (2006) 0.99
Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease. Eur J Neurosci (2006) 0.99
Hereditary spastic paraplegia: clinical genetic study of 15 families. Arch Neurol (2004) 0.99
Tissue plasminogen activator is required for corticostriatal long-term potentiation. Eur J Neurosci (2002) 0.99
Loss of muscarinic autoreceptor function impairs long-term depression but not long-term potentiation in the striatum. J Neurosci (2008) 0.99